Cancer prevention and screening: the next step in the era of precision medicine

被引：127

作者：

Loomans-Kropp, Holli A. ^{[1
,2
]}

Umar, Asad ^{[1
]}

机构：

[1] NCI, Canc Prevent Fellowship Program, Div Canc Prevent, Rockville, MD 20850 USA

[2] NCI, Gastrointestinal & Other Canc Branch, Div Canc Prevent, Rockville, MD USA

来源：

NPJ PRECISION ONCOLOGY | 2019年 / 3卷 / 1期

关键词：

CELL-FREE DNA; COLORECTAL-CANCER; BREAST-CANCER; LUNG-CANCER; BARRETTS-ESOPHAGUS; AMERICAN SOCIETY; NECK-CANCER; HIGH-RISK; FUTURE; WOMEN;

D O I：

10.1038/s41698-018-0075-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A primary mode of cancer prevention and early detection in the United States is the widespread practice of screening. Although many strategies for early detection and prevention are available, adverse outcomes, such as overdiagnosis and overtreatment, are prevalent among those utilizing these approaches. Broad use of mammography and prostate cancer screening are key examples illustrating the potential harms stemming from the detection of indolent lesions and the subsequent overtreatment. Furthermore, there are several cancers for which prevention strategies do not currently exist. Clinical and experimental evidence have expanded our understanding of cancer initiation and progression, and have instructed the development of improved, precise modes of cancer prevention and early detection. Recent cancer prevention and early detection innovations have begun moving towards the integration of molecular knowledge and risk stratification profiles to allow for a more accurate representation of at-risk individuals. The future of cancer prevention and early detection efforts should emphasize the incorporation of precision cancer prevention integration where screening and cancer prevention regimens can be matched to one's risk of cancer due to known genomic and environmental factors.

引用

页数：8

共 94 条

[71] Assessment of Erlotinib as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer Patients [J].

Rosenthal, Eben L. ;

Chung, Thomas K. ;

Carroll, William R. ;

Clemons, Lisa ;

Desmond, Renee ;

Nabell, Lisle .

ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (13) :4263-4269

[72] Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic [J].

Saba, Nabil F. ;

Hurwitz, Selwyn J. ;

Kono, Scott A. ;

Yang, Chung S. ;

Zhao, Yang ;

Chen, Zhengjia ;

Sica, Gabe ;

Mueller, Susan ;

Moreno-Williams, Rachel ;

Lewis, Melinda ;

Grist, William ;

Chen, Amy Y. ;

Moore, Charles E. ;

Owonikoko, Taofeek K. ;

Ramalingam, Suresh ;

Beitler, Jonathan J. ;

Nannapaneni, Sreenivas ;

Shin, Hyung Ju C. ;

Grandis, Jennifer R. ;

Khuri, Fadlo R. ;

Chen, Zhuo Georgia ;

Shin, Dong M. .

CANCER PREVENTION RESEARCH, 2014, 7 (03) :283-291

[73] Cell-free DNA as a diagnostic marker for cancer: current insights [J].

Salvi, Samanta ;

Gurioli, Giorgia ;

De Giorgi, Ugo ;

Conteduca, Vincenza ;

Tedaldi, Gianluca ;

Calistri, Daniele ;

Casadio, Valentina .

ONCOTARGETS AND THERAPY, 2016, 9 :6549-6559

[74]

Santos Sandra Cristina Dias dos, 2017, J. Coloproctol. (Rio J.), V37, P55, DOI 10.1016/j.jcol.2016.06.005

[75] Evolution of cervical cancer screening and prevention in United States and Canada: Implications for public health practitioners and clinicians [J].

Saraiya, M. ;

Steben, M. ;

Watson, M. ;

Markowitz, L. .

PREVENTIVE MEDICINE, 2013, 57 (05) :426-433

[76] Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial [J].

Shieh, Yiwey ;

Eklund, Martin ;

Madlensky, Lisa ;

Sawyer, Sarah D. ;

Thompson, Carlie K. ;

Fiscalini, Allison Stover ;

Ziv, Elad ;

van't Veer, Laura J. ;

Esserman, Laura J. ;

Tice, Jeffrey A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (05)

[77] Addressing the challenges of applying precision oncology [J].

Shin, Seung Ho ;

Bode, Ann M. ;

Dong, Zigang .

NPJ PRECISION ONCOLOGY, 2017, 1

[78] Colorectal cancer statistics, 2023 [J].

Siegel, Rebecca L. ;

Wagle, Nikita Sandeep ;

Cercek, Andrea ;

Smith, Robert A. ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (03) :233-254

[79] Cancer Screening in the United States, 2018: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening [J].

Smith, Robert A. ;

Andrews, Kimberly S. ;

Brooks, Durado ;

Fedewa, Stacey A. ;

Manassaram-Baptiste, Deana ;

Saslow, Debbie ;

Brawley, Otis W. ;

Wender, Richard C. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (04) :297-316

[80] The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory [J].

Soto, Ana M. ;

Sonnenschein, Carlos .

BIOESSAYS, 2011, 33 (05) :332-340

← 1 2 3 4 5 6 7 8 9 10 →